News, views and contacts from the global Drugdevelopment industry

Catenion: Press Releases

Make An Enquiry

Catenion to Attend Bio Europe Spring 2011 Wednesday, February 02, 2011 by Catenion Catenion is proud to announce that it will attend Bio-Europe Spring 2011 in Milan, Italy. This partnering conference will be held on 14-16 March at the Milano Convention Centre (MIC). ...

Strategic M&A Support for Pharmaceutical and Biotech Companies - Minimising the Risk of 'Winner's Curse' Tuesday, January 04, 2011 by Catenion In a risky business driven by innovation, M&A is a vital stra­tegic lever to counterbalance the in-built volatility of the R&D pipeline. In fact, there are many more reasons for frequent M&A...

Catenion Introduces Pre-Due Diligence and Due Diligence Support Thursday, December 09, 2010 by Catenion Licensing and M&A activity has continued unabated in the bio-pharmaceutical space. The reasons are the impending patent cliff, which a number of the larger players have to face, as well as...

Upcoming Challenges for the Japanese Pharmaceutical Industry Tuesday, November 02, 2010 by Catenion The Japanese pharmaceutical industry accounts for more than 1,000 firms, of which approximately 20 have annual sales of more than $500m. It is a widespread view in the West that the...

Risk Profiles of Corporate Portfolio Strategies - A Perspective for the Pharmaceutical Executive Thursday, July 22, 2010 by Catenion The current meltdown of some segments of the global banking system can be seen as a direct result of systemic weaknesses in the way that many financial services companies operated in a...

Introducing the Ideal Pharmaceutical Teaching Tool: Risky Business, The Pharmaceutical Industry Board Game Thursday, May 20, 2010 by Catenion Risky Business, the pharmaceutical industry board game, is becoming a must-have when it comes to teaching about the pharmaceutical industry. Risky Business is a strategy training workshop...